公司盈利预测
Search documents
百利电气:预计2025年度净利润为8000万元至10000万元
Zheng Quan Ri Bao· 2026-01-29 13:53
(文章来源:证券日报) 证券日报网讯 1月29日,百利电气发布公告称,公司预计2025年年度实现归属于母公司所有者的净利润 为8000万元至10000万元。 ...
上海凤凰(600679.SH):预计2025年度净利润1.2亿元左右
Ge Long Hui A P P· 2026-01-29 08:17
格隆汇1月29日丨上海凤凰(维权)(600679.SH)公布,经财务部门初步测算,预计2025年度实现归属于 上市公司股东的净利润与上年同期相比,将出现盈利,2025年度预计实现归属于上市公司股东的净利润 为12,000.00万元左右。2025年度公司实现归属于上市公司股东的扣除非经常性损益的净利润为6,200.00 万元左右。 报告期内,公司聚焦主营业务发展,积极优化业务结构,持续加强市场开拓,优化生产运营效率,严控 成本费用,报告期内,公司主营业务收入稳步增长,盈利能力不断提升,为公司扭亏为盈奠定了坚实基 础。 ...
*ST新潮:预计2025年净利润11.1亿元
Ge Long Hui· 2026-01-28 10:58
格隆汇1月28日丨*ST新潮(600777.SH)公布,经财务部门初步测算,公司预计2025年年度实现利润总额 141,000万元,预计2025年年度归属于母公司所有者的净利润为111,000万元,扣除非经常性损益后的净 利润为111,040万元。 ...
27日投资提示:龙大转债提议下修
集思录· 2026-01-26 13:19
Group 1 - Jianlong Micro-Nano plans to reduce its shareholding by no more than 2% [1] - Meinuohua expects a full-year profit of 100 million to 123 million in 2025, representing a year-on-year growth of 49.69% to 84.11% [1] - Qixiang Tengda anticipates a full-year loss of 660 million to 470 million in 2025 [1] Group 2 - Aojia Convertible Bond and Huahai Convertible Bond will not undergo adjustments [1] - The proposed adjustment for Longda Convertible Bond is scheduled for January 27, 2026 [1] - Various convertible bonds have specific details regarding their current prices, redemption prices, last trading dates, and conversion values [4][6]
Intuitive Surgical (ISRG) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
ZACKS· 2026-01-16 15:15
Core Viewpoint - Intuitive Surgical, Inc. (ISRG) is expected to report quarterly earnings of $2.25 per share, reflecting a 1.8% increase year-over-year, with revenues forecasted to remain unchanged at $0 million [1] Earnings Estimates - Revisions to earnings estimates are crucial indicators for predicting investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock performance [2] Revenue Projections - Analysts project 'Revenue- Product (Instruments and accessories and Systems)' to be $2.31 billion, indicating an 11.7% year-over-year increase [4] - 'Revenue- Services' is expected to reach $403.40 million, reflecting a 16.1% year-over-year increase [4] - 'Revenue- Systems' is forecasted at $660.60 million, showing a 0.9% year-over-year change [4] - The consensus estimate for 'Revenue- Instruments and accessories' stands at $1.65 billion, indicating a 16.7% year-over-year increase [5] - 'Instruments and accessories Revenue- United States' is estimated at $1.15 billion, reflecting a 13.8% year-over-year increase [5] - 'Systems Revenue- United States' is projected to be $374.31 million, indicating an 11% decrease from the prior-year quarter [5] - 'Instruments and accessories Revenue- Outside of the United States' is expected to reach $480.60 million, reflecting a 19.1% year-over-year increase [6] - 'Geographic Revenue- United States' is projected at $1.78 billion, indicating a 7.6% year-over-year increase [6] System Units and Installed Base - Analysts forecast 'Total System Units Placed - Total Company' to reach 503, up from 493 in the same quarter last year [7] - The average prediction for 'Da Vinci Surgical System Installed Base' is 11,122, compared to 9,902 in the same quarter last year [7] - 'Total System Units Placed - Outside of the United States' is expected to be 202, down from 209 in the same quarter last year [8] - 'Total System Units Placed - United States' is projected to reach 305, up from 284 in the same quarter of the previous year [8] Stock Performance - Over the past month, shares of Intuitive Surgical have returned -3.7%, while the Zacks S&P 500 composite has changed by +2% [8] - ISRG currently holds a Zacks Rank 2 (Buy), suggesting potential outperformance in the near future [8]
ABM Industries (ABM) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
ZACKS· 2025-12-12 15:16
Core Viewpoint - Analysts expect ABM Industries to report quarterly earnings of $1.10 per share, reflecting a year-over-year increase of 22.2%, with revenues projected at $2.27 billion, up 4.2% from the previous year [1]. Revenue Estimates - Revenues from Business & Industry are expected to reach $1.04 billion, indicating a year-over-year change of +1.7% [4]. - Revenues from Aviation are forecasted at $290.34 million, showing a year-over-year increase of +5% [4]. - Revenues from Education are projected to be $236.37 million, reflecting a year-over-year change of +2.8% [4]. - Revenues from Manufacturing & Distribution are estimated at $403.50 million, indicating a year-over-year change of +4.1% [5]. - Revenues from Technical Solutions are expected to arrive at $298.84 million, showing a significant year-over-year increase of +16.1% [5]. Operating Profit Estimates - Operating profit for Business & Industry is expected to be $111.70 million, compared to $72.00 million in the same quarter last year [6]. - Operating profit for Aviation is projected at $24.47 million, up from $18.60 million in the previous year [6]. - The consensus estimate for Operating profit in Manufacturing & Distribution stands at $51.21 million, compared to $40.40 million a year ago [7]. - Analysts expect Operating profit for Technical Solutions to reach $34.23 million, up from $28.00 million in the same quarter last year [7]. - The estimated Operating profit for Education is $19.40 million, contrasting with the year-ago figure of $13.10 million [8]. Stock Performance - Shares of ABM Industries have shown a return of +10.7% over the past month, outperforming the Zacks S&P 500 composite, which changed by +0.9% [8].
Crown Holdings, Inc. (CCK) Overview and Analyst Insights
Financial Modeling Prep· 2025-10-20 00:00
Core Viewpoint - Crown Holdings, Inc. has experienced a slight decrease in the consensus price target, reflecting a more conservative outlook from analysts, despite some optimism regarding its future performance [2][5]. Group 1: Company Overview - Crown Holdings, Inc. is a well-established company that designs, manufactures, and sells packaging products and equipment for various industries, including consumer goods and industrial products [1]. - The company was founded in 1892 and is headquartered in Yardley, Pennsylvania, operating in a competitive market with key players like Ball Corporation and Ardagh Group [1]. Group 2: Price Target and Analyst Outlook - The consensus price target for Crown Holdings has decreased from $116.5 to $110 over the past year, indicating a conservative outlook from analysts [2][5]. - Despite the decrease, the price target has remained stable over the last quarter and month, suggesting that analysts' views have recently stabilized [2]. - Gabe Hajde from Wells Fargo has set a higher price target of $152, reflecting confidence in the stock's potential [2]. Group 3: Earnings Predictions - Analysts predict a decline in Crown Holdings' earnings in the upcoming financial report, with Gabe Hajde noting that the company may lack the necessary factors to surpass earnings expectations [3]. - Despite the predicted decline in earnings, Crown Holdings has been upgraded to a Zacks Rank 2 (Buy), indicating optimism about its future performance [3][5]. Group 4: Factors Influencing Stock Price - Investors should consider recent company developments, earnings reports, and industry trends that could impact Crown Holdings' stock price [4][5]. - Factors such as changes in raw material costs, shifts in consumer demand, and global economic conditions can influence the company's financial performance and analysts' price targets [4].
Seeking Clues to O'Reilly Automotive (ORLY) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
ZACKS· 2025-10-17 14:16
Core Viewpoint - Analysts project O'Reilly Automotive (ORLY) will report quarterly earnings of $0.83 per share, a 9.2% increase year over year, with revenues expected to reach $4.7 billion, up 7.6% from the same quarter last year [1]. Earnings Projections - The consensus EPS estimate has been revised down by 0.4% in the past 30 days, reflecting a reassessment by covering analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Key Metrics Estimates - Sales to Do-It-Yourself Customers are expected to reach $2.37 billion, indicating a 6.8% increase from the prior year [5]. - Other sales and sales adjustments are projected at $119.61 million, reflecting a 2.7% increase year over year [5]. - Sales to professional service provider customers are estimated at $2.22 billion, suggesting a 9.5% year-over-year change [5]. Store and Square Footage Estimates - Total square footage is expected to be 50 million square feet, up from 48 million square feet in the same quarter last year [6]. - The total number of stores is projected to reach 6,534, compared to 6,291 a year ago [6]. - The ending domestic store count is anticipated to be 6,402, an increase from 6,187 in the same quarter last year [6]. Additional Store Metrics - The number of stores opened is likely to be 47, consistent with the previous year's figure [7]. - The ending Canada store count is expected to remain at 26, unchanged from the prior year [7]. - Domestic new stores opened are projected at 40, up from 35 a year ago [8]. - Mexico stores at the end of the period are estimated at 107, compared to 78 last year [8]. - Sales per weighted-average square foot are expected to reach $93.73 million, up from $89.17 million year over year [8]. Overall Performance - O'Reilly Automotive shares have shown a return of -2.4% over the past month, while the Zacks S&P 500 composite has increased by 0.7% [9]. - With a Zacks Rank 4 (Sell), ORLY is expected to underperform the overall market in the near future [9].
Unveiling Agilent (A) Q3 Outlook: Wall Street Estimates for Key Metrics
ZACKS· 2025-08-22 14:15
Core Viewpoint - Agilent Technologies is expected to report quarterly earnings of $1.37 per share, a 3.8% increase year-over-year, with revenues projected at $1.66 billion, reflecting a 5.1% year-over-year increase [1]. Financial Projections - Analysts have not revised the consensus EPS estimate for the quarter in the last 30 days, indicating stability in forecasts [2]. - Revisions to earnings projections are crucial for predicting investor behavior and stock price performance [3]. Revenue Estimates by Segment - The estimated 'Net Revenue- Life Sciences and Diagnostics Markets Segment' is $631.29 million, showing a year-over-year decrease of 19.3% [5]. - 'Net Revenue- Agilent Crosslab Group' is expected to reach $720.15 million, indicating a significant year-over-year increase of 75.2% [5]. - 'Revenue by End Markets- Chemical and advanced materials' is projected at $376.71 million, reflecting a 5.8% increase from the prior year [6]. - 'Revenue by End Markets- Environmental and Forensics' is estimated at $170.70 million, with a year-over-year change of 1.6% [6]. - 'Revenue by End Markets- Diagnostics and Clinical' is expected to be $249.80 million, indicating a 3.2% increase from the previous year [7]. - The consensus for 'Revenue by End Markets- Academia and Government' stands at $137.61 million, reflecting a year-over-year increase of 7.5% [7]. - 'Revenue by End Markets- Pharmaceutical' is projected at $581.31 million, indicating a year-over-year increase of 7.7% [7]. - 'Revenue by End Markets- Food' is expected to reach $150.33 million, reflecting a 4.4% increase from the prior year [8]. Stock Performance - Over the past month, Agilent shares have decreased by 2.7%, while the Zacks S&P 500 composite has increased by 1.1% [8]. - Agilent holds a Zacks Rank 3 (Hold), suggesting its performance will likely align with the overall market in the upcoming period [8].
The Cooper Companies (COO) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
ZACKS· 2025-08-22 14:15
Core Insights - Analysts project The Cooper Companies (COO) will report quarterly earnings of $1.06 per share, a 10.4% increase year over year, with revenues expected to reach $1.07 billion, reflecting a 6.2% increase from the same quarter last year [1] - The consensus EPS estimate has remained unchanged over the last 30 days, indicating a collective reevaluation by analysts [1][2] Revenue Estimates - Revenue by Category - CVI is forecasted to reach $723.97 million, indicating a year-over-year change of +7.2% [4] - Revenue by Category - CSI is expected to be $343.37 million, suggesting a change of +4.9% year over year [4] - Revenue by Category - CSI - Office and surgical is projected at $209.17 million, reflecting a +5.7% change from the prior-year quarter [4] - Revenue by Category - CSI - Fertility is estimated at $134.62 million, indicating a +4.1% change from the year-ago quarter [5] - Revenue by Category - CVI - Sphere, other is predicted to be $371.00 million, showing a +6.2% change from the year-ago quarter [5] - Revenue by Category - CVI - Toric and multifocal is expected to reach $352.82 million, indicating an +8.1% change from the prior-year quarter [6] Geographic Revenue Estimates - Revenue by Geography - Americas is projected at $311.49 million, reflecting a +11.3% change from the year-ago quarter [6] - Revenue by Geography - Asia Pacific is expected to be $143.68 million, suggesting a +3.1% year-over-year change [6] - Revenue by Geography - EMEA is forecasted to reach $267.71 million, indicating a +4.4% year-over-year change [7] Stock Performance - Shares of The Cooper Companies have shown a return of -1% over the past month, compared to the Zacks S&P 500 composite's +1.1% change [7] - The company holds a Zacks Rank 3 (Hold), indicating expectations to mirror overall market performance in the near future [7]